Ruoying H. Yu

Nanjing, 210032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study).

A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study).

Journal: Cancers

Published: August 10, 2023

Clinical value of FAT1 mutations to indicate the immune response in colorectal cancer patients.

Clinical value of FAT1 mutations to indicate the immune response in colorectal cancer patients.

Journal: Genomics

Published: July 20, 2023

Comprehensive genomic profiling of colorectal cancer patients reveals differences in mutational landscapes among clinical and pathological subgroups.

Comprehensive genomic profiling of colorectal cancer patients reveals differences in mutational landscapes among clinical and pathological subgroups.

Journal: Frontiers in oncology

Published: July 21, 2022

Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer.

Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer.

Journal: Molecular oncology

Published: May 06, 2022

Clinical and molecular characteristics of kinase domain duplications across diverse cancer types in the Chinese population.

Clinical and molecular characteristics of kinase domain duplications across diverse cancer types in the Chinese population.

Journal: Cancer medicine

Published: May 04, 2022

Rapid subcutaneous progression after immunotherapy in pretreated patients with metastatic carcinoma: two case reports.

Rapid subcutaneous progression after immunotherapy in pretreated patients with metastatic carcinoma: two case reports.

Journal: The Journal of international medical research

Published: April 26, 2022

Pan-cancer molecular analysis of EGFR large fragment deletion in the Asian population.

Pan-cancer molecular analysis of EGFR large fragment deletion in the Asian population.

Journal: Cancer medicine

Published: March 31, 2022

Clinical Outcome-Related Cancer Pathways and Mutational Signatures in Patients With Unresectable Esophageal Squamous Cell Carcinoma Treated With Chemoradiotherapy.

Clinical Outcome-Related Cancer Pathways and Mutational Signatures in Patients With Unresectable Esophageal Squamous Cell Carcinoma Treated With Chemoradiotherapy.

Journal: International journal of radiation oncology, biology, physics

Published: February 24, 2022

Clinical implications of EGFR-associated MAPK/ERK pathway in multiple primary lung cancer.

Clinical implications of EGFR-associated MAPK/ERK pathway in multiple primary lung cancer.

Journal: Clinical and translational medicine

Published: December 30, 2021

Application of Metagenomic Next-Generation Sequencing in the Etiological Diagnosis of Infective Endocarditis During the Perioperative Period of Cardiac Surgery: A Prospective Cohort Study.

Application of Metagenomic Next-Generation Sequencing in the Etiological Diagnosis of Infective Endocarditis During the Perioperative Period of Cardiac Surgery: A Prospective Cohort Study.

Journal: Frontiers in cardiovascular medicine

Published: November 08, 2021

Pathway-Based Analysis Revealed the Role of Keap1-Nrf2 Pathway and PI3K-Akt Pathway in Chinese Esophageal Squamous Cell Carcinoma Patients With Definitive Chemoradiotherapy.

Pathway-Based Analysis Revealed the Role of Keap1-Nrf2 Pathway and PI3K-Akt Pathway in Chinese Esophageal Squamous Cell Carcinoma Patients With Definitive Chemoradiotherapy.

Journal: Frontiers in genetics

Published: October 21, 2021

Molecular landscape and therapeutic alterations in Asian soft-tissue sarcoma patients.

Molecular landscape and therapeutic alterations in Asian soft-tissue sarcoma patients.

Journal: Cancer medicine

Published: September 29, 2021

Showing 1-12 of 35

Last Updated: 09/26/2026